Patent ID: 9713572
Date: 2017-07-25
CPC Classifications: A61J,A61K,C03C,C07K,Y10T

Claim:
1. A pharmaceutical composition product comprising: pertuzumab, tocilizumab, trastuzumab emtansine, MetMAb (onartuzumab), obinutuzumab, ocrelizumab or lebrikizumab and a pharmaceutically acceptable excipient; contained within a glass pharmaceutical container a glass composition comprising: SiO alkaline earth oxide comprising both MgO and CaO, wherein CaO is present in an amount up to about 1.0 mol. %, and a ratio (CaO (mol. %)/(CaO (mol. %)+MgO (mol. %))) is less than or equal to 0.5; X mol. % Al Y mol. % alkali oxide, wherein the alkali oxide comprises Na a ratio of a concentration of B